U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H5Cl2NO
Molecular Weight 214.048
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLOROXINE

SMILES

OC1=C2N=CC=CC2=C(Cl)C=C1Cl

InChI

InChIKey=WDFKMLRRRCGAKS-UHFFFAOYSA-N
InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H

HIDE SMILES / InChI

Molecular Formula C9H5Cl2NO
Molecular Weight 214.048
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Chloroxine, a dichloroquinolinol, was first prepared by A. Hebebrand in 1888. It is an antibacterial drug that has been incorporated into shampoos to treat dandruff and seborrheic dermatitis. It has also been used internally as an antidiarrheal and in the lab as an analytical reagent. The drug was withdrawn from the market in the US by unknown reason.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CAPITROL

Approved Use

Unknown

Launch Date

1976
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
0.713 μg/g
2 μL single, oral
dose: 2 μL
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROXINE plasma
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
60.72 μg × min/mL
2 μL single, oral
dose: 2 μL
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROXINE plasma
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
48.72 min
2 μL single, oral
dose: 2 μL
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLOROXINE plasma
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: studies on their mode of action.
1991
Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites.
1994 May 1
Solid phase extractive preconcentration of thorium onto 5,7-dichloroquinoline-8-ol modified benzophenone.
2002 Oct 16
A monooxygenase catalyzes sequential dechlorinations of 2,4,6-trichlorophenol by oxidative and hydrolytic reactions.
2004 Feb 20
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
2005
Solid phase extraction preconcentration of cobalt and nickel with 5,7-dichloroquinone-8-ol embedded styrene-ethylene glycol dimethacrylate polymer particles and determination by flame atomic absorption spectrometry (FAAS).
2005 Apr 15
Selective recognition of neodymium (III) using ion imprinted polymer particles.
2005 Jan-Feb
Prediction of genotoxicity of chemical compounds by statistical learning methods.
2005 Jun
Ion imprinted polymer particles for separation of yttrium from selected lanthanides.
2006 Jun
The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes.
2006 Mar 15
Investigation of the role of chelating ligand in the synthesis of ion-imprinted polymeric resins on the selective enrichment of uranium(VI).
2007 Mar 28
Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
2007 Nov 1
Synthesis of nano-pore samarium (III)-imprinted polymer for preconcentrative separation of samarium ions from other lanthanide ions via solid phase extraction.
2008 Aug 8
5,7-Dichloro-quinolin-8-ol.
2009 Apr 25
N,N-Dicyclo-hexyl-2-(5,7-dichloro-8-quinol-yloxy)acetamide.
2009 Oct 7
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.
2013 Mar 28
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Chloroxine is used as a topical shampoo containing 2% (w/w) chloroxine.
Apply onto the wet scalp, leave on for approximately three minutes, then rinse.
Route of Administration: Topical
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:13:57 GMT 2023
Edited
by admin
on Fri Dec 15 15:13:57 GMT 2023
Record UNII
2I8BD50I8B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLOROXINE
MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN  
Official Name English
5,7-Dichloro-8-quinolinol
Systematic Name English
CHLOROXINE [USAN]
Common Name English
Chloroxine [WHO-DD]
Common Name English
CHLOROXINE [MART.]
Common Name English
8-QUINOLINOL, 5,7-DICHLORO-
Systematic Name English
CAPITROL
Brand Name English
CHLOROXINE [ORANGE BOOK]
Common Name English
NSC-3904
Code English
CHLOROXINE [VANDF]
Common Name English
CHLOROXINE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29708
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
212-258-3
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
MESH
C004357
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
ChEMBL
CHEMBL1200596
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
PUBCHEM
2722
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
FDA UNII
2I8BD50I8B
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
NSC
3904
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
WIKIPEDIA
Chloroxine
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
CHEBI
59477
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
EVMPD
SUB13339MIG
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
DRUG BANK
DB01243
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
SMS_ID
100000091041
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
DRUG CENTRAL
611
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
CAS
773-76-2
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
NCI_THESAURUS
C47446
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
EPA CompTox
DTXSID5022801
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY
RXCUI
20875
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m3451
Created by admin on Fri Dec 15 15:13:57 GMT 2023 , Edited by admin on Fri Dec 15 15:13:57 GMT 2023
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY